Marianna Fedorenko's Avatar

Marianna Fedorenko

@mariannaw.bsky.social

Mom of 3, wife, Antibiotic steward, ID pharmacist, science nerd. Former New Yorker->NJ suburbs. Medical Science Director @Melinta. All opinions are my own.

1,710 Followers  |  1,688 Following  |  5 Posts  |  Joined: 08.11.2024  |  1.8574

Latest posts by mariannaw.bsky.social on Bluesky

Post image

πŸ†• MMWR: In NYC, NDM-CRE just surpassed KPC-CRE for the first time.

And nearly 75% of these cases had no long-term care facility link

This is a changing landscape of antibiotic resistance - happening across US

#IDSky
πŸ“„: www.cdc.gov/mmwr/volumes...

10.07.2025 17:10 β€” πŸ‘ 8    πŸ” 3    πŸ’¬ 3    πŸ“Œ 2
Propensity score-weighted analysis of the impact of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation on unscheduled care Outpatient parenteral antimicrobial therapy (OPAT) is a mechanism for delivery of antimicrobial therapy outside of inpatient care; however, risks associated with OPAT combined with transition-of-care vulnerabilities may result in unscheduled healthcare use. On 6/15/2020, our institution launched a program entailing OPAT plan review and reconciliation by infectious diseases (ID) pharmacists prior to hospital discharge. We analyzed the frequency of all-cause 90-day emergency department (ED) visits, readmissions, and mortality of patients pre- and post-implementation of OPAT plan reconciliation.MethodsUnique, adult OPAT recipients discharged to home or a post-acute care facility from an academic hospital before (6/1/2017-6/14/2020) and after (6/15/2020-6/30/2022) implementation of ID pharmacist review and reconciliation of OPAT plans were included. We performed a propensity score-weighted analysis to compare 90-day outcomes pre- and post-intervention while adjusting for relevant clinical characteristics. We accounted for missing data by using multiple imputation.ResultsA total of 2408 OPAT patients met inclusion criteria: 1650 pre-implementation and 758 post-implementation. Patients in the post-implementation group had statistically fewer ED visits (pre: 22.2%; post: 17.8%; p = 0.02) and hospital readmissions (pre: 38.9%; post: 33.4%; p = 0.01) within 90 days after discharge from index admission when compared to the pre-implementation cohort. There was no significant difference in the 90-day all-cause mortality between cohorts.ConclusionsFollowing implementation of OPAT plan reconciliation by ID pharmacists prior to discharge to home from acute care, OPAT recipients were significantly less likely to experience 90-day ED visits or 90-day readmissions.

πŸ“‰ OPAT plan review by ID pharmacists reduced 90-day ED visits from 22.2% to 17.8% (p=0.02) & readmissions from 38.9% to 33.4% (p=0.01). No change in mortality. πŸ₯

#idsky

12.06.2025 23:30 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

MDR-GNB infections remain a major global health challenge. With new diagnostics & antibiotics emerging, we’re at a crossroads.
Fantastic πŸ†•πŸ’«review about MDR GN by Dr. Nenad Macesic
Figures🌟 #idsky
www.thelancet.com/journals/lan...

22.01.2025 15:21 β€” πŸ‘ 24    πŸ” 6    πŸ’¬ 4    πŸ“Œ 0
Post image

#IDsky

Winter is coming, and so is influenza! Reminder to get your flu shot πŸ’‰ if you haven’t already.

Folks, it’s starting. Be ready.

gis.cdc.gov/GRASP/Fluvie...

12.12.2024 01:08 β€” πŸ‘ 41    πŸ” 9    πŸ’¬ 2    πŸ“Œ 2

Feel better!!

11.12.2024 20:18 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Happy Thanksgiving to you too!

27.11.2024 21:48 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Happy Antibiotic Awareness Week! #IDSky #MedSky #Stewardship

18.11.2024 14:42 β€” πŸ‘ 9    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Global distribution of KPC (A), NDM (B), and OXA-48-like (C) carbapenemases.

Global distribution of KPC (A), NDM (B), and OXA-48-like (C) carbapenemases.

Phenotypic and immunochromatographic assays for the detection of carbapenemase-producing carbapenem-resistant organisms.

Phenotypic and immunochromatographic assays for the detection of carbapenemase-producing carbapenem-resistant organisms.

Selecting a carbapenemase confirmation test for suspect clinical isolates based on cost and complexity

Selecting a carbapenemase confirmation test for suspect clinical isolates based on cost and complexity

Appearance of carbapenem-resistant organisms on selective chromogenic media.

Appearance of carbapenem-resistant organisms on selective chromogenic media.

Laboratory detection of carbapenemases among Gram-negative organisms

Patricia Simner, Johan Pitout, and Tanis Dingle 🀩

#ClinMicroReviews

journals.asm.org/doi/10.1128/... (Paywall) #IDSky #MicroSky

15.11.2024 16:41 β€” πŸ‘ 50    πŸ” 14    πŸ’¬ 2    πŸ“Œ 1
Preview
a woman is making a funny face with her mouth open and her eyes closed . ALT: a woman is making a funny face with her mouth open and her eyes closed .

Thats horrifying

14.11.2024 14:38 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

What?!? I knew there was a book 2 but not 3 or 4. Now, I will have to go read them. Thank you!

13.11.2024 01:51 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

What's up, IDSky?

08.11.2024 21:45 β€” πŸ‘ 70    πŸ” 8    πŸ’¬ 11    πŸ“Œ 3

The Upper East Side has great places to eat- I used to live there. Try Amarena, 83 1/2, JoJo by Jean-Georges, Caledonia (bar); coffee: Hutch and Waldo, 787 coffee, Sant Ambroeus (coffee shop inside Sotheby’s), gelato: Anita gelato

11.11.2024 17:33 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

sharing some starter packets curated by @timomoilanen.bsky.social and @germhuntermd.bsky.social

Genomic epidemiology: go.bsky.app/AZgp9Ko
IDSky 1: go.bsky.app/LnAQjdq
IDSky 2: go.bsky.app/JNfSvQT
Epidemiologists of Bluesky: go.bsky.app/3cn51fN
AMR: go.bsky.app/KkZfvrh

08.11.2024 17:53 β€” πŸ‘ 20    πŸ” 11    πŸ’¬ 1    πŸ“Œ 0

@mariannaw is following 20 prominent accounts